The Sherman Food, Drug, and Cosmetic Law regulates the packaging, labeling, and advertising of drugs and devices, and is administered by the State Department of Public Health. The law prohibits the sale, delivery, or giving away of any new drug or new device unless either the department has approved a new drug or device application for that new drug or new device and that approval has not been withdrawn, terminated, or suspended or a new drug application has been approved for it and that approval has not been withdrawn, terminated, or suspended under specified provisions of the Federal Food, Drug, and Cosmetic Act, or it is a new device for which a premarket approval application has been approved, and that approval has not been withdrawn, terminated, or suspended under the federal act.
California AB 1277 (20112012) — Sherman Food, Drug, and Cosmetic Law.
The Sherman Food, Drug, and Cosmetic Law regulates the packaging, labeling, and advertising of drugs and devices, and is administered by the State Department of Public Health. The law prohibits the sale, delivery, or giving away of any new drug or new device unless either the department has approved a new drug or device application for that new drug or new device and that approval has not been withdrawn, terminated, or suspended or a new drug application has been approved for it and that approval has not been withdrawn, terminated, or suspended under specified provisions of the Federal Food, Drug, and Cosmetic Act, or it is a new device for which a premarket approval application has been approved, and that approval has not been withdrawn, terminated, or suspended under the federal act.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
Do pass and be re-referred to the Committee on Business, Professions and Consumer Protection. — 17–0 (pass) · lower
Do pass and re-refer to Committee on Appropriations with recommendation: To Consent Calendar. — 9–0 (pass) · lower
Do pass, to Consent Calendar. — 16–0 (pass) · lower
AB 1277 HILL Consent Calendar Second Day — 78–0 (pass) · lower
Special Consent #16 AB1277 Hill By Rubio — 37–0 (pass) · upper
AB 1277 HILL Concurrence in Senate Amendments — 80–0 (pass) · lower
Do pass as amended, and re-refer to the Committee on Appropriations. — 7–0 (pass) · upper
Sponsors
Hill — primary (person)
Alejo — coauthor (person)
Blakeslee — coauthor (person)
Fletcher — coauthor (person)
Padilla — coauthor (person)
Pan — coauthor (person)
Perea — author (person)
Smyth — coauthor (person)
Timeline
The legislative action history — every referral, reading, and vote.
2011-02-18 Read first time. To print. reading-1
2011-02-20 From printer. May be heard in committee March 22.
2011-03-31 Referred to Coms. on HEALTH and B., P. & C.P. referral-committee
2011-03-31 From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended. reading-2, amendment-introduction, reading-1, amendment-passage
2011-04-04 Re-referred to Com. on HEALTH. referral-committee
2011-04-13 From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended. reading-2, amendment-introduction, reading-1, amendment-passage
2011-04-14 Re-referred to Com. on HEALTH. referral-committee
2011-04-27 From committee: Do pass and re-refer to Com. on B., P. & C.P. (Ayes 17. Noes 0.) (April 26). Re-referred to Com. on B., P. & C.P. referral-committee, committee-passage, committee-passage-favorable
2011-05-04 From committee: Do pass and re-refer to Com. on APPR. with recommendation: to consent calendar. (Ayes 9. Noes 0.) (May 3). Re-referred to Com. on APPR. referral-committee, committee-passage, committee-passage-favorable
2011-05-12 From committee: Do pass. To consent calendar. (Ayes 16. Noes 0.) (May 11). committee-passage, committee-passage-favorable
2011-05-16 Read second time. Ordered to consent calendar. reading-2, reading-1
2011-05-19 Read third time. Passed. Ordered to the Senate. (Ayes 78. Noes 0. Page 1453.) reading-3, reading-1, passage
2011-05-19 In Senate. Read first time. To Com. on RLS. for assignment. reading-1
2011-06-02 Referred to Com. on HEALTH. referral-committee
2011-06-15 In committee: Set, first hearing. Hearing canceled at the request of author.
2011-06-29 From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on HEALTH. reading-2, amendment-introduction, reading-1, amendment-passage, referral-committee
2011-07-05 In committee: Set, second hearing. Hearing canceled at the request of author.
2012-01-04 From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on HEALTH. reading-2, amendment-introduction, reading-1, amendment-passage, referral-committee
2012-06-11 In committee: Hearing postponed by committee.
2012-06-20 From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on HEALTH. reading-2, amendment-introduction, reading-1, amendment-passage, referral-committee
2012-07-03 From committee: Do pass as amended and re-refer to Com. on APPR. (Ayes 7. Noes 0.) (June 27). amendment-passage, committee-passage, committee-passage-favorable
2012-07-05 Read second time and amended. Re-referred to Com. on APPR. reading-2, reading-1, amendment-passage, referral-committee
2012-08-06 From committee: Be placed on second reading file pursuant to Senate Rule 28.8. committee-passage
2012-08-07 Read second time. Ordered to third reading. reading-2, reading-1
2012-08-09 Read third time and amended. Ordered to second reading. reading-3, reading-1, amendment-passage
2012-08-13 Read second time. Ordered to third reading. reading-2, reading-1
2012-08-15 Ordered to special consent calendar.
2012-08-23 Read third time. Passed. Ordered to the Assembly. (Ayes 37. Noes 0. Page 4784.). reading-3, reading-1, passage
2012-08-24 In Assembly. Concurrence in Senate amendments pending. May be considered on or after August 28 pursuant to Assembly Rule 77.